Free Trial
NASDAQ:JYNT

Joint (JYNT) Stock Price, News & Analysis

Joint logo
$9.08 -0.22 (-2.37%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$9.04 -0.04 (-0.44%)
As of 10/3/2025 05:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Joint Stock (NASDAQ:JYNT)

Advanced

Key Stats

Today's Range
$8.93
$9.34
50-Day Range
$9.08
$11.70
52-Week Range
$8.93
$13.47
Volume
107,868 shs
Average Volume
95,340 shs
Market Capitalization
$139.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.33
Consensus Rating
Moderate Buy

Company Overview

Joint Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
76th Percentile Overall Score

JYNT MarketRank™: 

Joint scored higher than 76% of companies evaluated by MarketBeat, and ranked 220th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Joint has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    Joint has a consensus price target of $16.33, representing about 79.9% upside from its current price of $9.08.

  • Amount of Analyst Coverage

    Joint has only been the subject of 2 research reports in the past 90 days.

  • Read more about Joint's stock forecast and price target.
  • Earnings Growth

    Earnings for Joint are expected to grow by 381.82% in the coming year, from $0.11 to $0.53 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Joint is -27.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Joint is -27.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Joint has a P/B Ratio of 6.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Joint's valuation and earnings.
  • Percentage of Shares Shorted

    4.40% of the float of Joint has been sold short.
  • Short Interest Ratio / Days to Cover

    Joint has a short interest ratio ("days to cover") of 8.5.
  • Change versus previous month

    Short interest in Joint has recently increased by 10.58%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Joint does not currently pay a dividend.

  • Dividend Growth

    Joint does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.40% of the float of Joint has been sold short.
  • Short Interest Ratio / Days to Cover

    Joint has a short interest ratio ("days to cover") of 8.5.
  • Change versus previous month

    Short interest in Joint has recently increased by 10.58%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Joint has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Joint this week, compared to 3 articles on an average week.
  • Search Interest

    11 people have searched for JYNT on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Joint insiders have bought more of their company's stock than they have sold. Specifically, they have bought $367,641.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    27.90% of the stock of Joint is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    76.88% of the stock of Joint is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Joint's insider trading history.
Receive JYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

JYNT Stock News Headlines

The Joint Chiropractic Debuts in Delaware
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.tc pixel
See More Headlines

JYNT Stock Analysis - Frequently Asked Questions

Joint's stock was trading at $10.63 at the beginning of 2025. Since then, JYNT stock has decreased by 14.6% and is now trading at $9.08.

The Joint Corp. (NASDAQ:JYNT) announced its quarterly earnings results on Thursday, August, 7th. The company reported ($0.06) EPS for the quarter, beating the consensus estimate of ($0.07) by $0.01. The company earned $13.27 million during the quarter, compared to analyst estimates of $13.32 million. Joint had a positive trailing twelve-month return on equity of 0.60% and a negative net margin of 7.02%.
Read the conference call transcript
.

Joint's board authorized a share repurchase program on Thursday, June 5th 2025, which allows the company to buy back $5,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 2.7% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's board believes its stock is undervalued.

Joint (JYNT) raised $20 million in an initial public offering on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager.

Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Joint investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
8/07/2025
Today
10/04/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - HMO
Sub-Industry
Trading
Current Symbol
NASDAQ:JYNT
CIK
1612630
Employees
320
Year Founded
1999

Price Target and Rating

High Price Target
$18.00
Low Price Target
$15.00
Potential Upside/Downside
+79.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.33)
Trailing P/E Ratio
N/A
Forward P/E Ratio
82.55
P/E Growth
N/A
Net Income
-$5.80 million
Net Margins
-7.02%
Pretax Margin
-1.40%
Return on Equity
0.60%
Return on Assets
0.16%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.80
Quick Ratio
1.80

Sales & Book Value

Annual Sales
$51.90 million
Price / Sales
2.68
Cash Flow
$0.64 per share
Price / Cash Flow
14.23
Book Value
$1.38 per share
Price / Book
6.58

Miscellaneous

Outstanding Shares
15,340,000
Free Float
11,062,000
Market Cap
$139.29 million
Optionable
Optionable
Beta
1.45

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:JYNT) was last updated on 10/4/2025 by MarketBeat.com Staff
From Our Partners